NXL Stock Chart & Stats
$0.25
-$0.02(-3.33%)
At close: 4:00 PM EDT
$0.25
-$0.02(-3.33%)
Day’s Range― - ―
52-Week Range$6.25 - $60.00
Previous CloseN/A
Volume45.34K
Average Volume (3M)7.42K
Market Cap
$6.00M
Enterprise Value$6.88M
Total Cash (Recent Filing)$1.00M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.51
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.48
Shares Outstanding829,400
10 Day Avg. Volume10,949
30 Day Avg. Volume7,419
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)2.44
Price to Sales (P/S)30.32
P/FCF Ratio-1.85
Enterprise Value/Market Cap1.15
Enterprise Value/Revenue31.69
Enterprise Value/Gross Profit-21.35
Enterprise Value/Ebitda-0.77
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-11.4
Revenue Forecast (FY)$345.00K
Nexalin Technology, Inc. News
NXL FAQ
What was Nexalin Technology, Inc.’s price range in the past 12 months?
Nexalin Technology, Inc. lowest stock price was $6.25 and its highest was $60.00 in the past 12 months.
What is Nexalin Technology, Inc.’s market cap?
Nexalin Technology, Inc.’s market cap is $6.00M.
When is Nexalin Technology, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Nexalin Technology, Inc.’s earnings last quarter?
Currently, no data Available
Is Nexalin Technology, Inc. overvalued?
According to Wall Street analysts Nexalin Technology, Inc.’s price is currently Overvalued.
Does Nexalin Technology, Inc. pay dividends?
Nexalin Technology, Inc. does not currently pay dividends.
What is Nexalin Technology, Inc.’s EPS estimate?
Nexalin Technology, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nexalin Technology, Inc. have?
Nexalin Technology, Inc. has 829,400 shares outstanding.
What happened to Nexalin Technology, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Nexalin Technology, Inc.?
Currently, no hedge funds are holding shares in NXL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Nexalin Technology, Inc.
Nexalin Technology, Inc. operates as a medical device firm specializing in the creation and advancement of neurostimulation therapies for mental health conditions in both the United States and China. The company commercializes its primary product, the Nexalin Device, which provides a non-invasive and drug-free treatment for anxiety and insomnia. This device functions by emitting a proprietary frequency-based waveform designed to elicit a beneficial response from mid-brain structures associated with various psychological disorders. Furthermore, Nexalin Technology is currently developing "Generation 2," a new medical device undergoing clinical trials. This future product aims to address a broader spectrum of health issues, including opiate addiction, persistent pain, Alzheimer's disease, and dementia. The company was founded in 2021 and has its headquarters in Houston, Texas.
Technical Analysis
Ownership Overview
16.72% Insiders
1.02% Mutual Funds
0.18% Other Institutional Investors
81.56% Public Companies and
Individual Investors